Cetilistat 282526-98-1 Factory direct sales diabetes obesity

Synopsis Cetilistat (ATL-962), also known as Cetilistat, is a novel pancreatic lipase inhibitor for the treatment of diabetes and obesity in non-diabetic patients. Neollistat is also called Cetilistat, Cellistat, Cetilista, like white to white crystalline powder, soluble in methanol, main uses: Chemicalbook new weight loss drug, and can be used in smoking cessation; Indications: new weight loss, smoking cessation, blood lipid lowering, pharmaceutical raw materials. Neolistat is a long-acting and potent inhibitor of specific gastrointestinal lipase. It acts as a therapeutic agent by forming covalent bonds with the active serine sites of gastric and pancreatic lipase in the stomach and small intestine to inactivate enzymes that are unable to hydrolyze food fats, mainly triglycerides, into absorbable free fatty acids and monacylglycerol. Undigested triglycerides cannot be absorbed by the body, thereby reducing calorie intake and controlling weight. Bioactive Cetilistat(ATL962) is a highly lipophilic benzoxazinone that inhibits gastrointestinal and pancreatic lipases (lipases). In vivo, it has a good safety and tolerance.